---
figid: PMC7098936__10354_2020_741_Fig1_HTML
figlink: pmc/articles/PMC7098936/figure/Fig1/
number: F1
caption: Drugs in development for the treatment of achondroplasia. Depicted is a growth
  plate chondrocyte. The main targets are FGFR3 ligands, the mutated FGFR3 and its
  activated downstream MAPK signalling pathway, as well as the NPR‑B receptor. In
  bold are substances currently in clinical trials (as of November 30, 2019). The
  complex MAPK pathway which originates from FGFR3, as well the MAPK-inhibitory pathway
  that originates from NPR‑B activation, are depicted for simplification
pmcid: PMC7098936
papertitle: New developments in the management of achondroplasia.
reftext: Wolfgang Högler, et al. Wien Med Wochenschr. 2020;170(5):104-111.
pmc_ranked_result_index: '20641'
pathway_score: 0.9561362
filename: 10354_2020_741_Fig1_HTML.jpg
figtitle: Drugs in development for the treatment of achondroplasia
year: '2020'
organisms:
- Mus musculus
- Rattus norvegicus
- Macaca fascicularis
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7098936__10354_2020_741_Fig1_HTML.html
  '@type': Dataset
  description: Drugs in development for the treatment of achondroplasia. Depicted
    is a growth plate chondrocyte. The main targets are FGFR3 ligands, the mutated
    FGFR3 and its activated downstream MAPK signalling pathway, as well as the NPR‑B
    receptor. In bold are substances currently in clinical trials (as of November 30,
    2019). The complex MAPK pathway which originates from FGFR3, as well the MAPK-inhibitory
    pathway that originates from NPR‑B activation, are depicted for simplification
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK14
  - MAPK3
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK1
  - MAPK9
  - MAPK10
  - FGFR3
  - FGF2
  - NPR2
  - MAP2K1
  - MAP2K2
  - CNP
  - FRS2
  - ARAF
  - BRAF
  - RAF1
  - SOS1
  - SOS2
  - GRB2
  - HRAS
  - KRAS
  - NRAS
  - Meclozine
  - BMN111
  - Tyrosine
  - BGJ398
genes:
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: FGFR3
  symbol: FGFR3
  source: hgnc_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: FGF2
  symbol: FGF2
  source: hgnc_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: 'NPR-B:'
  symbol: NPRB
  source: hgnc_prev_symbol
  hgnc_symbol: NPR2
  entrez: '4882'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: CNP
  symbol: CNP
  source: hgnc_symbol
  hgnc_symbol: CNP
  entrez: '1267'
- word: FRS2
  symbol: FRS2
  source: hgnc_symbol
  hgnc_symbol: FRS2
  entrez: '10818'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: FGFR3
  symbol: FGFR3
  source: hgnc_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: NPR-B
  symbol: NPRB
  source: hgnc_prev_symbol
  hgnc_symbol: NPR2
  entrez: '4882'
- word: FGFR3
  symbol: FGFR3
  source: hgnc_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: GRB2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: 'FGFR3:'
  symbol: FGFR3
  source: hgnc_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: CNP
  symbol: CNP
  source: hgnc_symbol
  hgnc_symbol: CNP
  entrez: '1267'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: FGFR3
  symbol: FGFR3
  source: hgnc_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
chemicals:
- word: Meclozine
  source: MESH
  identifier: D008468
- word: BMN111
  source: MESH
  identifier: C578282
- word: Tyrosine
  source: ''
  identifier: ''
- word: BGJ398
  source: MESH
  identifier: C568950
diseases: []
figid_alias: PMC7098936__F1
redirect_from: /figures/PMC7098936__F1
figtype: Figure
---
